[Ultrastructural events associated with the action of tolbutamide and glybenclamide on pancreatic B-cells in vivo and in vitro].
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002462:Cell Membrane; D002463:Cell Membrane Permeability; D003593:Cytoplasm; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006056:Golgi Apparatus / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000032:analysis / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000032:analysis / Q000166:cytology* / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008854:Microscopy, Electron; D008928:Mitochondria / Q000378:metabolism; D010101:Oxygen Consumption; D014176:Protein Biosynthesis; D051381:Rats; D012995:Solubility; D013449:Sulfonamides / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013449:Sulfonamides; D014044:Tolbutamide